首页> 中文期刊> 《中华放射肿瘤学杂志 》 >CT引导术中实时计划对胸部肿瘤125Ⅰ粒子植入治疗的价值

CT引导术中实时计划对胸部肿瘤125Ⅰ粒子植入治疗的价值

摘要

目的 探讨CT引导下计算机三维治疗计划系统(TPS)术中实时治疗计划在125 Ⅰ粒子植入治疗胸部肿瘤中应用的必要性和可行性.方法 对2010-2012年间31例行125Ⅰ粒子治疗的胸部肿瘤患者资料进行回顾分析,其中13例术中行TPS实时计划优化(A组),余18例未行术中实时计划(B组).按经验间隔1 cm植入粒子,所有患者处方剂量110 Gy,术后均行TPS质量验证.并在B组原术中影像资料上重新模拟实时计划(C组),比较各组质量验证满意率.采用x2检验差异.结果 A、B组术后质量验证满意率分别为92%、39% (P=0.003),C组重新模拟计划后满意率为94%,也高于B组(P=0.001),但与A组相似(P=0.811).结论 术中实时治疗计划在CT引导下125Ⅰ粒子治疗胸部肿瘤可显著提高肿瘤靶区剂量满意率,具有可操作性,对胸部肿瘤粒子治疗的规范化具有重要价值.%Objective To explore the necessity and feasibility of the real-time treatment planning optimization by CT guided with 125Ⅰ seed implantation brachytherapy treatment to thoracic malignancies.Methods To retrospectively analyze the data of 31 inpatients (from October 2010 to June 2012) with thoracic malignancie by CT guidance 125Ⅰ brachytherapy.The real-time planning optimization were applicated to 13 cases (group A),18 patients undergoing experience particles implantation interval 1 cm (group B),all the patients were prescribed dose 110 Gy and post-planning verified after surgery.Re-simulation of realtime program (group C) about the image data in group B,data analysis was x2-test by SPSS 13.0 software.Results The quality verification in two groups were 92% and 39%,the difference was statistically sifnificant (P =0.003).The re-simulation program in group C was 94%,there was significant difference compared with group B (P =0.001),but with no significant difference compared with group A (P =0.811).Conclusions The application of intraoperative real-time planning by CT guided with 125Ⅰ seed implantation brachytherapy to thoracic malignancies,non-equidistant layout that be the real implantedneedle trajectory based on dosimetry,can significantly improve the tumor target dose,operational,there was greatly important value to the standardization of the particle therapy of thoracic malignancies.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号